Approximately 98% of CML patients exhibit BCR::ABL1 mRNA transcripts with a fusion of either BCR exon 13 or 14 with ABL1 exon 2. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.